CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
25.41
-0.15 (-0.59%)
At close: Aug 20, 2025, 9:45 AM
CG Oncology Common stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Revenue | n/a | 52K | 456K | 43K | 111K | 529K | 1K | 9K | n/a | 194K | n/a |
Cost of Revenue | 156K | n/a | n/a | n/a | 7K | 4K | 4K | -7.83M | 4K | 7.84M | 4K |
Gross Profit | -156K | 52K | 456K | 43K | 111K | 525K | -3K | 9K | -4K | -7.65M | -4K |
Operating Income | -48.74M | -42.2M | -38.05M | -28.3M | -25.85M | -22.47M | -18.93M | -14.47M | -12.33M | -9.72M | -9.31M |
Interest Income | 7.32M | 7.75M | 6.25M | 7.89M | 6.94M | 5.55M | 2.82M | 2.28M | 771K | 1.05M | n/a |
Pretax Income | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.12M | -12.21M | -11.61M | -8.67M | -8.39M |
Net Income | n/a | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.12M | -12.21M | -11.61M | -8.67M | -8.39M |
Selling & General & Admin | 17.41M | 14.79M | 11.71M | 8.72M | 7.49M | 5.78M | 3.01M | 2.31M | 2.49M | 2.07M | 1.65M |
Research & Development | 31.33M | 27.47M | 26.8M | 19.62M | 18.47M | 17.21M | 15.91M | 12.16M | 9.83M | 7.84M | 7.66M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -58K | 8K | 13K |
Operating Expenses | 48.74M | 42.26M | 38.51M | 28.34M | 25.96M | 22.99M | 18.93M | 14.47M | 12.32M | 9.91M | 9.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -4K | -4K | n/a | -4K | n/a | -4K |
Cost & Expenses | 48.74M | 42.26M | 38.51M | 28.34M | 25.96M | 23M | 18.93M | 14.47M | 12.33M | 9.91M | 9.31M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
Shares Outstanding (Diluted) | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
EPS (Basic) | -0.54 | -0.45 | -0.49 | -0.3 | -0.28 | -0.25 | -0.33 | -0.28 | -0.17 | -0.13 | -0.13 |
EPS (Diluted) | -0.54 | -0.45 | -0.49 | -0.3 | -0.28 | -0.22 | -0.33 | -0.28 | -0.17 | -0.13 | -0.13 |
EBITDA | -48.74M | -42.18M | -38.05M | -28.27M | -25.85M | -22.46M | -18.93M | -14.46M | -12.32M | -9.72M | -9.31M |
EBIT | -41.43M | -42.2M | -38.05M | -28.3M | -25.85M | -22.47M | -18.93M | -14.47M | -12.33M | -9.72M | -9.51M |
Depreciation & Amortization | n/a | 24K | -32K | 21K | 7K | 4K | 4K | 5K | 4K | 4K | 4K |